Home
<
Home
Investors
<
Investors
News
<
News
Investor FAQs
<
Investor FAQs
Analysts Coverage
<
Analysts Coverage
Stock Information
<
Stock Information
M&A Activities
<
M&A Activities
Corporate Governance
<
Corporate Governance
Shareholder Services
<
Shareholder Services
Financial Information
<
Financial Information
Products
<
Products
What We Treat
<
What We Treat
Key Products
<
Key Products
Drug Safety
<
Drug Safety
Quality
<
Quality
Patent Notices
<
Patent Notices
Medical Information
<
Medical Information
R & D
<
R & D
We Live Open Science
<
We Live Open Science
R&D Areas of Focus
<
R&D Areas of Focus
Clinical Trials
<
Clinical Trials
Pre-Approval Access
<
Pre-Approval Access
About
<
About
Company Profile
<
Company Profile
Executive Leadership
<
Executive Leadership
Global Footprint
<
Global Footprint
Global Locations
<
Global Locations
Contact
<
Contact
News
<
News
Press Releases
<
Press Releases
Media Contacts
<
Media Contacts
Newsroom
<
Newsroom
Careers
<
Careers
Career Opportunities
<
Career Opportunities
Working at Allergan
<
Working at Allergan
Our Employees
<
Our Employees
Fellowship Program
<
Fellowship Program
Responsibility
<
Responsibility
Social Contract
<
Social Contract
Social Responsibility
<
Social Responsibility
Allergan Foundation
<
Allergan Foundation
California Supply Chain Disclosure
<
California Supply Chain Disclosure
Alliance Support and IME Grants
<
Alliance Support and IME Grants
Health Care Provider Partnerships & Payments
<
Health Care Provider Partnerships & Payments
Patient Resources
<
Patient Resources
Patient Safety & Product Quality
<
Patient Safety & Product Quality
Physician Resources
<
Physician Resources
Animal Testing
<
Animal Testing
Home
Investors
Products
R & D
About
News
Careers
Responsibility
Search
Home >
Investors >
Read the full story>
Allergan Acquisition: Investor Information
News
Events & Presentations
Investor FAQs
Analysts Coverage
Stock Information
Stock Chart & Quote
Historical Price Lookup
Investment Calculator
Preferred Shares
M&A Activities
Allergan Acquisition
Forest Laboratories Acquisition
Warner Chilcott Acquisition
Teva Agreement
Corporate Governance
Executive Officers and Directors
Committee Composition
Committee Charters
Code of Conduct
Governance Guidelines
Insider Transactions
Allergan Compliance Program
Memorandum of Association
Shareholder Services
Information Requests
Investor Kit
E-mail Alerts
Dividends
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Proxy Materials
Corporate Fact Sheet
Products >
What We Treat
Key Products
Our Products
Product Prescribing
Drug Safety
Quality
Patent Notices
Medical Information
Medical Information Request
R & D >
We Live Open Science
R&D Areas of Focus
Allergan Pipeline
Advancing the Pipeline
Clinical Trials
Participating in an Allergan Clinical Trial
Clinical Trial results sharing
Post Marketing Commitments
Sharing Patient-Level Data
Clinical Trials Investigators
Investigator Initiated Trials
Pre-Approval Access
About >
LEARN MORE>
A global Growth Pharma leader
Company Profile
Executive Leadership
Global Footprint
Pharmaceuticals
Business Development
Global Locations
Commercial Operations
Supply Chain
Countries
Contact
News >
CEO Blog
Press Releases
Media Contacts
Newsroom
Allergan Images
Allergan Logos
Company Profile
Executive Bios & Photos
Careers >
Career Opportunities
Working at Allergan
Our Employees
Albert Yao
Caitlin Sandahl
Angela Hodge
Jose Miguel Herrera
Shuyan Li
Christine Birchnall
Fellowship Program
Responsibility >
LEARN MORE>
High priorities: sustainability & continual improvement
Social Contract
Social Responsibility
Community
Sustainability
Environmental
Employees
Facilities & Manufacturing
Partners
Public Policy
Allergan Foundation
California Supply Chain Disclosure
Alliance Support and IME Grants
Alliance Support
Independent Medical Education Grants
Health Care Provider Partnerships & Payments
Affordable Care Act
Patient Resources
Patient Assistance Programs
Patient Safety & Product Quality
Research and Development
Risks and Benefits
Quality
Physician Resources
Animal Testing
>Go!
Investors
>
News
News
Events & Presentations
Investor FAQs
Analysts Coverage
Stock Information
M&A Activities
Corporate Governance
Shareholder Services
Financial Information
News
Investor Press Releases
Filter
Filter
Content
Investors
Filter
Year
2016
2015
2014
2013
2012
2011
2010
2009
11.02.2010 | Investors
Watson Signs Exclusive Agreement to Distribute Authorized Generic Concerta(R)
10.29.2010 | Investors
Watson To Present At The 2010 Credit Suisse Healthcare Conference
10.27.2010 | Investors
Watson Confirms Crestor(R) Patent Challenge
10.15.2010 | Investors
Watson's Generic Version of Lotrel (R) Receives FDA Approval
10.12.2010 | Investors
Watson to Host Conference Call and Webcast to Discuss Third Quarter 2010 Earnings
10.07.2010 | Investors
Watson Reaches Settlement with Endo Over Opana(R) ER
10.05.2010 | Investors
Watson Confirms Azilect(R) Patent Challenge
10.04.2010 | Investors
Watson, Moksha8 Form Marketing Partnership for Brazil, Mexico; Watson Makes Initial $30 Million Investment
09.28.2010 | Investors
Watson to Present at the Jefferies 2010 Global SpecPharma & European Healthcare Conference
09.17.2010 | Investors
HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
Page 77 of 90
Contact us
If you have questions about the Company or request additional information, please contact Allergan
Country Websites
Global
Corporate Website
Africa
Egypt
South Africa
Americas
Argentina
Barbados
Bolivia
Brazil
Canada
Chile
Colombia
Costa Rica
Dominican Republic
Ecuador
El Salvador
Guatemala
Honduras
Jamaica
Mexico
Panama
Peru
Puerto Rico
Trinidad & Tobago
Uruguay
Venezuela
Asia Pacific
Australia
Bahrain
Bangladesh
China
Hong Kong
India
Indonesia
Isreal
Japan
Jordan
Korea
Kuwait
Lebanon
Malaysia
New Zealand
Pakistan
Palestine
Philippines
Saudi Arabia
Singapore
Sri Lanka
Taiwan
Thailand
United Arab Emirates
Vietnam
Europe
Austria
Belgium
Bulgaria
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Malta
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom